Compare COO & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COO | DPZ |
|---|---|---|
| Founded | 1980 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 10.4B |
| IPO Year | 1994 | 2004 |
| Metric | COO | DPZ |
|---|---|---|
| Price | $70.19 | $286.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 24 |
| Target Price | $90.18 | ★ $434.29 |
| AVG Volume (30 Days) | ★ 3.5M | 859.3K |
| Earning Date | 05-28-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 5.27 |
| EPS | 0.27 | ★ 4.13 |
| Revenue | $2,532,800,000.00 | ★ $4,939,994,000.00 |
| Revenue This Year | $6.66 | $7.98 |
| Revenue Next Year | $5.18 | $3.97 |
| P/E Ratio | $254.70 | ★ $69.66 |
| Revenue Growth | ★ 18.41 | 4.96 |
| 52 Week Low | $58.89 | $282.00 |
| 52 Week High | $89.83 | $496.00 |
| Indicator | COO | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 66.45 | 31.75 |
| Support Level | $67.91 | N/A |
| Resistance Level | $72.59 | $323.20 |
| Average True Range (ATR) | 1.83 | 9.30 |
| MACD | 0.37 | -2.25 |
| Stochastic Oscillator | 81.50 | 10.41 |
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.